LDLR p.Thr389=
c.1167G>A · rs139066906 · VCV256365
ClinGen expert panel — Familial Hypercholesterolemia VCEP
Likely Benign for hypercholesterolemia, familial. Applied ACMG criteria (verbatim):
BP7 BP4
Curation rationale (ClinGen, verbatim)
The NM_000527.5(LDLR):c.1167G>A (p.Thr389=) variant is classified as likely benign for Familial Hypercholesterolemia by applying evidence codes: BP4, BP7 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: BP4 - No REVEL, splicing evaluation needed. Functional data on splicing not available. A) not on limits B) does not create GT Variant is not predicted to alter splicing BP7 - Variant is synonymous and meets BP4.
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 0.33 | GERP -1.9, phastCons 0.12 |
| Overall | ||
| CADD | 12.98 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.224% | 447 |
| Middle Eastern | 0.066% | 1,516 |
| Remaining individualsnot grpmax-eligible | 0.0416% | 2,404 |
| Admixed American | 0.0167% | 6,003 |
| South Asian | 0.00659% | 15,180 |
| European (non-Finnish) | 0.00136% | 73,744 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- LDLR
- Protein
- p.Thr389=
- Coding
- c.1167G>A
- MANE Select
- NM_000527
- dbSNP
- rs139066906
- Type
- single nucleotide variant
- Location
- chr19:11111620 (GRCh38)
- Gene constraint
- LOEUF 1.091 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 75.81 · 36 PDB
- Residue 389
- the egf-like 2; calcium-binding domain; a turn; a disulfide bond
Similar variants
- LDLR p.Thr389Ala Likely pathogenic ★ ⚠ same residue
- LDLR p.Thr389Lys Likely pathogenic ★ ⚠ same residue
- LDLR p.Thr389Arg Uncertain significance ★ ⚠ same residue
- LDLR p.Thr389Met Conflicting classifications of pathogenicity ★ ⚠ same residue
- LDLR c.1186+5G>A Likely pathogenic ★★★ same condition
- LDLR c.1359-1G>A Pathogenic ★★★ same condition
- LDLR c.1359-5C>G Likely pathogenic ★★★ same condition
- LDLR c.1705+2T>C Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ldlr-p-thr389 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown